Laird Norton Wetherby Trust Company’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.41M Buy
141,504
+5,283
+4% +$138K 0.07% 222
2026
Q1
$3.83M Sell
136,221
-13,638
-9% -$363K 0.08% 187
2025
Q4
$3.73M Buy
+149,859
New +$3.78M 0.08% 198
2025
Q1
Sell
-10,664
Closed -$283K 76
2024
Q4
$283K Hold
10,664
0.04% 61
2024
Q3
$309K Hold
10,664
0.04% 67
2024
Q2
$298K Hold
10,664
0.04% 53
2024
Q1
$296K Hold
10,664
0.04% 61
2023
Q4
$307K Buy
+10,664
New +$322K 0.04% 68
2023
Q2
Sell
-5,143
Closed -$210K 119
2023
Q1
$210K Sell
5,143
-1,131
-18% -$48.8K 0.03% 111
2022
Q4
$321K Buy
+6,274
New +$301K 0.05% 79
2022
Q3
Sell
-6,135
Closed -$321K 110
2022
Q2
$321K Sell
6,135
-466
-7% -$23.7K 0.04% 84
2022
Q1
$341K Sell
6,601
-318
-5% -$16.5K 0.03% 134
2021
Q4
$408K Sell
6,919
-472
-6% -$23.4K 0.04% 125
2021
Q3
$317K Buy
7,391
+1,488
+25% +$65.9K 0.03% 134
2021
Q2
$231K Sell
5,903
-834
-12% -$32.4K 0.02% 145
2021
Q1
$247K Sell
6,737
-826
-11% -$29.3K 0.03% 133
2020
Q4
$278K Buy
+7,563
New +$277K 0.03% 128

Other funds holding PFE

Laird Norton Wetherby Trust Company's PFE Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company increased its Pfizer (PFE) stake by 3.9% in Q2 2026, buying an estimated $138K and bringing the position to 141,504 shares worth $3.41M. The position accounts for 0.07% of the portfolio, ranked #222.

Laird Norton Wetherby Trust Company first reported a position in PFE in Q4 2020 and has held it in 17 quarters since. The position peaked at $3.83M in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Laird Norton Wetherby Trust Company held 141,504 shares of Pfizer worth $3.41M as of Q2 2026.
  • Laird Norton Wetherby Trust Company bought 5,283 Pfizer shares in Q2 2026, an estimated $138K.
  • Pfizer made up 0.07% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #222 holding.
  • Laird Norton Wetherby Trust Company first reported a position in Pfizer in Q4 2020 and has held it in 17 quarters since.
  • Laird Norton Wetherby Trust Company's Pfizer position peaked at $3.83M in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.